EU regulator approves fifth COVID-19 vaccine

EU regulator approves fifth COVID-19 vaccine
Photo is illustrative in nature. From open sources.

The European Medicines Agency (EMA) has recommended approval for the use of the Nuvaxovid vaccine from the American company Novavax, according to the regulator's website.

“After a thorough assessment, the EMA Committee for Medicinal Products for Human Use (CHMP) reached general agreement that the vaccine data were reliable and met EU criteria for efficacy, safety and quality,” the report said.

This is the fifth vaccine recommended for use in the EU. it will be used to vaccinate people over 18 years of age. According to two studies, the effectiveness of the vaccine is about 90%.

WHO allowed approval of Sputnik V in the first quarter of 2022 Society

The issuance of a conditional marketing authorization means that the drug is approved after receiving less complete information about it than is usually required. At the same time, the available data suggest that the risks do not exceed the benefits of the drug. Accelerated registration is associated with the need to close the medical need for this drug and obliges the manufacturer to provide full data on clinical trials in the future.

Read together with it: